Framework · Contracts Finder
Oncotype DX Breast Recurrence Score test
Groups 1 related procurement, worth £583.2k combined.
- 1
- Member contracts
- £583.2k
- Combined value
- 1
- Buyers
Oncotype DX Breast Recurrence Score test is a UK public-sector framework or programme that groups 1 related procurement worth £583.2k combined. The member contracts and call-offs below are run by 1 participating buyer.
Details
- Source
- Contracts Finder
- Member contracts
- 1
- Combined value
- £583,200
- First activity
- 2 Apr 2024
- Latest activity
- 2 Apr 2024
- Participating buyers
- 1
Member procurements
Contracts and call-offs grouped under this framework.
| Procurement | Buyer | Stage | Value |
|---|---|---|---|
| Oncotype DX Breast Recurrence Score test | Norfolk and Norwich University Hospitals NHS Foundation Trust | Award | £583.2k |
Participating buyers
FAQs about this framework
What is the "Oncotype DX Breast Recurrence Score test" framework?
It groups 1 related UK public procurement worth £583,200 combined, published via Contracts Finder.
Which buyers use this framework?
1 buyer participate, including Norfolk and Norwich University Hospitals NHS Foundation Trust.
When is this framework active?
Recorded activity runs from 2 Apr 2024 to 2 Apr 2024.
Get ahead on framework opportunities
Enable tracks frameworks and their call-offs across UK public procurement so you can position before the next mini-competition. Talk to us.
Get in touch with Enable